Stockreport
Gilead Surges To 2-Year High On Expectations For Speedy Coronavirus Drug [Investor's Business Daily]
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Related news 4:20 PM ET Three Biogen employees tested positive for Covid-19, a new form of coronavirus, after attending a meeting of about 175 people... Can Gilead Change Its Dim Fortunes On An Immuno-Oncology Buyout? How To Trade Stocks: Do You Know The Seven Most Important Words On Wall Street? Travel Curbs Tighten; Fiscal Packages Multiply: Virus Update Alnylam Unveils Powerhouse Match-Up To Tackle Coronavirus Outbreak Coronavirus News: As Covid-19 Infects Stock Market, Economy And Business Face Test Emergency Measures Go Global As Cases Top 90,000: Virus Update Thermo Fisher To Buy Qiagen For $10 Billion In Lab Tie-Up How Gilead's Newest Takeover Deal Will Bolster Its Cancer Strategy GILD stock popped Friday after an analyst suggested Gilead Sciences ( GILD ) could unveil the test results of a coronavirus treatment later this month. Officials in China are testing Gilead's drug, remdesivir, in two groups of patients with Covid-19, a
[Read more]
IMPACT SNAPSHOT | EVENT TIME: | GILD | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
LAST PRICE | ||
VWAP | ||
High:
|
MAX UP |
High:
|
Low:
|
MAX DOWN |
Low:
|
%
|
POST NEWS RANGE |
%
|
|
PRICE CHANGE |
|
|
PRICE CHANGE PERCENTAGE |
|
|
S&P 500 (SPX) |
|
%
|
VOLUME RATIO |
%
|
VOLUME (SHARES) | ||
TICKS | ||
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
GILD alerts
GILD alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
NEWS
NEWS
- The Jackson Laboratory and AbTherx Announce Partnership to Enhance Therapeutic Antibody Discovery [Yahoo! Finance][Yahoo! Finance]
- Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know Why Is Everyone Talking About Amazon Stock? Jeff Bezos' Most Prized Possession Breaks Historical Auction Records At Almost $53 Million Analyst adjusts Nvidia stoc[Acquire Media Monitor]
- Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program[Business Wire]
- Alcoholic Hepatitis Treatment Market To Reach USD 4.9 Billion By 2032 | DataHorizzon Research [Yahoo! Finance][Yahoo! Finance]
- Gilead's FOCUS Program Helps Zero In on Early HIV Detection [Yahoo! Finance][Yahoo! Finance]
- More
GILD
SEC Filings
SEC Filings
- 5/9/24 - Form 4
- 5/9/24 - Form 4
- 5/9/24 - Form 4
- GILD's page on the SEC website
- More